Scarica l'app Stockscreener
1.685
1.51%
0.025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Biovie Inc Borsa (BIVI) Ultime notizie
Can BioVie Inc. deliver alphaJuly 2025 Drop Watch & AI Driven Price Predictions - newsimpact.co.kr
Will BioVie Inc. announce a stock split2025 Volatility Report & Stepwise Trade Signal Guides - thegnnews.com
What hedge funds are buying BioVie Inc.Rate Hike & Weekly Setup with High ROI Potential - thegnnews.com
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - The Florida Times-Union
How high can BioVie Inc. stock price go in 2025Earnings Trend Report & Weekly High Conviction Ideas - Newser
Smart tools for monitoring BioVie Inc.’s price action2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser
Understanding BioVie Inc.’s price movementTake Profit & Long-Term Capital Growth Strategies - Newser
BioVie Inc. Presents Phase 2 ADDRESS-LC Trial Design for Bezisterim in Long COVID at Keystone Symposia - Quiver Quantitative
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design - GlobeNewswire
BioVie's Novel Long COVID Drug Trial Targets Brain Fog and Fatigue in 18M+ Americans - Stock Titan
BioVie Inc. stock prediction for this weekAI Trend Detection for Entry Timing - Newser
Sector ETF performance correlation with BioVie Inc.Entry and Exit Strategy for Swing Traders - Newser
BioVie Completes $10.4 Million Public Offering to Strengthen Financial Position - AInvest
Has BioVie Inc. found a price floorPortfolio Risk Distribution Analysis Tool - Newser
BioVie Completes $10.4 Million Public Offering - TipRanks
BioVie closes $12 million public offering of units - Investing.com
BioVie closes $12 million public offering of units By Investing.com - Investing.com UK
BioVie Inc. Announces Closing of $12 Million Public Offering - GlobeNewswire
BioVie Inc. Raises $12 Million Through Public Offering - AInvest
BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan
What machine learning models say about BioVie Inc.Real-Time Setup Summary with ROI Focus - Newser
Why BioVie Inc. stock is on top investor watchlistsReal-Time Investment Picks with Accuracy - Newser
What is the short-term price target for BIVI according to analyst ratings? - AInvest
Bloomberg to Air New to The Street Episode #683 Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - AInvest
BioVie stock dips on pricing $12M securities offering - MSN
BioVie Raises $12mln, Sees Upside to $55.00, Analysts Call it an "Outperform" Investment Opportunity - AInvest
BioVie Prices 6M Share Secondary at $2.00, Below Last Closing Price of $2.91 - AInvest
BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire
BioVie (BIVI.O) Crashes 42.78%: What's Behind the Sharp Intraday Move? - AInvest
Biovie stock plunges after pricing $12 million public offering By Investing.com - Investing.com Canada
Biovie stock plunges after pricing $12 million public offering - Investing.com
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga
BioVie's 45% Plunge: A Capital Raise Gone Wrong? - AInvest
US Stocks Surge as Dow Gains 300 Points, American Axle & Mfg Posts Upbeat Earnings - AInvest
Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings - Benzinga
BioVie Announces $12M Securities Offering - AInvest
BioVie's (BIVI) 43% Plunge: A Volatile Turn in the Biotech Arena? - AInvest
BioVie Stock Dips After Share Offering News - timothysykes.com
Why Is BioVie Stock (BIVI) Down 50% Today? - TipRanks
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan
BioVie prices $12 million public offering of units at $2.00 each - Investing.com
Biovie's $12M Equity Raise: Is This a Strategic Lifeline or a Warning Signal for Small-Cap Biotechs? - AInvest
BioVie Inc. Raises $12 Million in Public Offering - AInvest
Biovie announces pricing of $12 million public offering - MarketScreener
Biovie Announces Pricing Of $12 Million Public Offering - TradingView
BioVie Inc. Announces Pricing of $12 Million Public Offering - Benzinga
BioVie's Stock Plummets 26.6%: A Volatile Intraday Freefall Amid Regulatory and Market Pressures - AInvest
Real time scanner hits for BioVie Inc. explainedTrading Volume Anomaly Summary and Insight - Newser
What is the risk reward ratio of investing in BioVie Inc. stockHigh-velocity gains - Jammu Links News
Is it the right time to buy BioVie Inc. stockSkyrocketing profit margins - Jammu Links News
What catalysts could drive BioVie Inc. stock higher in 2025Achieve rapid returns with smart investment plans - Jammu Links News
Does BioVie Inc. stock perform well during market downturnsExplosive capital appreciation - Jammu Links News
How strong is BioVie Inc. company’s balance sheetUnprecedented profit potential - Jammu Links News
What are BioVie Inc. company’s key revenue driversInvest confidently with professional market insights - Jammu Links News
How does BioVie Inc. compare to its industry peersFree Risk Assessment Services - Jammu Links News
What institutional investors are buying BioVie Inc. stockStay ahead with advanced stock screening tools - Jammu Links News
Is BioVie Inc. stock overvalued or undervaluedMarket-beating returns - Jammu Links News
BioVie Inc. Stock Analysis and ForecastUnstoppable profit momentum - Jammu Links News
0.04%
1.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):